MedTrace Logo

Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00690482 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2014-01-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to study efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

Conditions

  • Moderate to Severe COPD

Interventions

DRUG

AZD1981

Oral tablet, twice daily

DRUG

Placebo

Placebo Oral tablet, twice daily

Sponsors & Collaborators

Principal Investigators

  • Jörgen Vestbo · Professor in Respiratory Medicine, Hvidovre, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Bulgaria
  • Denmark
  • Poland
  • Slovakia
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690482 on ClinicalTrials.gov